Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B) - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS2298

Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)

Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 18 cell line, 3 other, 2 protocol sets

Platform:: GPL97
Series:: GSE4342
18 Samples

DataSet

Accession:: GDS2298

ID:: 2298

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)
Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)
Accession: GDS2298

GEO DataSets
Related DataSets for GEO Profiles (Select 29744500) (1)
GEO DataSets
BRCA1 depletion effect on HeLa cells
BRCA1 depletion effect on HeLa cells
Accession: GDS3791

GEO DataSets
Related DataSets for GEO Profiles (Select 94843164) (1)
GEO DataSets
Related DataSets for GEO Profiles (Select 86799464) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets